Skip to main content
OpenTrials

Clinical trial condition

Cutaneous Squamous Cell Carcinoma

Explore clinical trials studying Cutaneous Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.

56 public trials 22 recruiting studies
Refine in advanced search Browse all conditions

Cutaneous Squamous Cell Carcinoma trial results

Active, not recruiting

Neoadjuvant Plus Adjuvant Treatment With Cemiplimab in Cutaneaous Squamous Cell Carcinoma

NCT04632433

Conditions
Cutaneous Squamous Cell Carcinoma
Locations
  • Azienda Ospedaliera Papa Giovanni XXIII Bergamo, Italy
  • Ospedale S.M. Annunziata - Azienda USL Toscana Centro Bagno a Ripoli, Firenze, Italy
  • IRCCS - Istituto Scientifico Romagnolo per la Cura e lo Studio dei Tumori (I.R.S.T) S.r.l. Meldola, Forlì-Cesena, Italy
  • Fondazione I.R.C.C.S. Istituto Nazionale dei Tumori Milan, Milano, Italy
View Trial Details
Active, not recruiting

Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers

NCT03212404

Conditions
Adenocarcinoma, Adenoma, Bronchial Neoplasms, +67 more
Locations
  • Research Site Wollongong, New South Wales, Australia
  • Research Site Benowa, Queensland, Australia
  • Research Site Buderim, Queensland, Australia
  • Research Site Greenslopes, Queensland, Australia
View all 48 locations
View Trial Details
Active, not recruiting

Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer

NCT04050436

Conditions
Advanced Cutaneous Squamous Cell Carcinoma, Carcinoma, Carcinoma, Squamous Cell, +6 more
Locations
  • University of California San Diego La Jolla, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Stanford University Stanford, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
View all 56 locations
View Trial Details
Completed

Study of Favezelimab Coformulated With Pembrolizumab (MK-4280A) in Participants With Selected Solid Tumors (MK-4280A-010)

NCT06036836

Conditions
Cutaneous Squamous Cell Carcinoma, Endometrial Cancer, Endometrial Neoplasms, +13 more
Locations
  • Yale-New Haven Hospital-Yale Cancer Center ( Site 0643) New Haven, Connecticut, United States
  • Dana-Farber Cancer Institute ( Site 0642) Boston, Massachusetts, United States
  • Rutgers Cancer Institute of New Jersey ( Site 0635) New Brunswick, New Jersey, United States
  • Duke Cancer Institute ( Site 0641) Durham, North Carolina, United States
View all 44 locations
View Trial Details
Completed

Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma

NCT03082534

Conditions
Carcinoma, Carcinoma, Squamous Cell, Cutaneous Squamous Cell Carcinoma, +37 more
Locations
  • UCSD Moores Cancer Center La Jolla, California, United States
  • University of California Los Angeles Cancer Center Los Angeles, California, United States
  • University of Michigan Cancer Center Ann Arbor, Michigan, United States
  • Washington School of Medicine Cancer Center St Louis, Missouri, United States
View Trial Details

Related conditions